More than 27 years of experience in clinical translation of cellular therapies and regenerative medicine products including entrepreneurial and business management and board directorship experience. Eight years’ experience as an executive officer with a publicly traded company building services for cellular banking including global licensure of technology. An experienced scientist delivering innovation, driving milestones, maintain sensitivity to financial considerations, building high performance multidisciplinary teams, strategic planning, project management, and regulatory expertise. She has lead research & development of tissue/cellular products for service enhancement or commercialization and has extensive experience in tissue/cellular procurement, processing, tissue engineering, cryopreservation, cellular selection/separation, expansion, tissue/cell culture, quality systems compliance, internal/external inspections and transferring technology. Leads a clinical translation team streamlining development to create a robust pipeline of products in early phase clinical trials and FDA registered products including cell therapy, tissue engineered organs and tissues, biomaterials and devices.